Adjuvant treatment is given with curative intent to kill any cancer cells left behind after surgery, with the goal of keeping you cancer-free for as long as possible. Keep in mind that even if you get adjuvant treatment, the cancer may still return. In addition, some people may experience ...
Various approaches have been devised to improve the treatment outcomes of rectal cancer. These include new surgical methods5 and use of adjuvant treatment. However, there are lots of controversies concerning the extent of the surgery and the use of adjuvant treatment for different surgical approaches...
6. He J,Su C,Liang W,et al. Icotinib versus chemotherapy as adjuvant treatment for stage Ⅱ~ ⅢA EGFR-mutant non-small-cell lung cancer(EVIDENCE): a randomised, open-label , phase 3trial[J]. Lancet Respir Med,20...
Adjuvant systemic therapy in early-stage breast cancer Agents used in adjuvant breast cancer systemic therapy include the following [1] : Taxanes (docetaxel, paclitaxel) - Among the most active and commonly used chemotherapeutic agents for the treatment of early-stage breast cancer Cyclophosphamide - ...
6. He J,Su C,Liang W,et al. Icotinib versus chemotherapy as adjuvant treatment for stage Ⅱ~ ⅢA EGFR-mutant non-small-cell lung cancer(EVIDENCE): a randomised, open-label , phase 3trial[J]. Lancet Respir Med,2021,9(9):1021-1029. ...
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.J Clin Oncol1998, 16:301–308. Twelves C, Wong A, Nowacki MP,et al.:Capecitabine as adjuvant treatment for stage III colon cancer.N Engl J ...
Lowell Hart, MD, FACP:Well, in a broad way of speaking the systemic adjuvant treatment of early breast cancer falls into 2 groups. There’s the chemotherapy side and the hormonal therapy side. For a postmenopausal woman like this, the hormone therapy side would be either an aromatase inhibito...
During the past four decades, especially in recent years, various active adjuvant therapies combined with surgery have improved the outcome in cases of cancer of the esophagus. However, no optimum adjuvant therapy has been determined. From 1981 to 1992, 341 patients with regional and distant node...
(There wasn’t a control group because no standard of treatment existed at that time.) After a median follow-up of 4 years, patients had a 3-year DFS of 98.7% and few serious adverse events. In the recent secondary analysis, the 7-year DFS was 93.3% with only 4 (1.0%) dist...
Howard S. Hochster, MD, FACP: All of the studies that looked at HIPEC really look at IV [intravenous] chemotherapy versus surgery plus the intraperitoneal treatment. It’s the surgery that really makes a difference, in my opinion. There’s no good study of surgery debulking with or without...